Glob­al li­cense pro­gram to re­ceive Covid-19 sup­port from the NIH

A WHO pro­gram will see some sup­port from the Biden ad­min­is­tra­tion in the fight against Covid-19.

At the sec­ond Glob­al Covid-19 Sum­mit, the ad­min­is­tra­tion, through the NIH, has de­cid­ed to of­fi­cial­ly li­cense 11 Covid-19 re­search tools and ear­ly-stage vac­cine and di­ag­nos­tic can­di­dates. This will be done through the Med­i­cines Patent Pool (MPP), a UN-backed pro­gram, through WHO’s Tech­nol­o­gy Ac­cess Pool (C-TAP).

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN